Lipid-Optimized Sulfone-Bridged Cidofovir Prodrugs as Potent Antivirals Against Orthopoxviruses
Baogang Wang1, Panpan Wei1,2, Shaowen Shi3,4
1State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medicine Sciences, Academy of Military Sciences, Beijing 100071, China.
Abstract:
The unprecedented global mpox outbreak highlights the urgent need for novel orthopoxvirus antivirals. In this study, we rationally designed and synthesized a series of cidofovir (CDV) prodrugs conjugated with diverse lipid chains via sulfur-containing bridge moieties. Structure-activity relationship analyses identified the sulfone group as optimal, with a C2H4 linker and an approximately 20-atom chain length providing ideal antiviral potency. Compound 13f exhibited antiviral activity against vaccinia virus (VACV) comparable to that of the reference brincidofovir (BCV), while 13i displayed 8.2-fold enhanced potency. Both derivatives demonstrated superior potency against monkeypox virus (MPXV) compared to BCV. Stability tests in biorelevant media and pharmacokinetic evaluations confirmed favorable oral formulation characteristics for 13f and 13i. Notably, 13i exhibited a favorable safety profile and significant therapeutic efficacy in both VACV-challenged BALB/c and MPXV-challenged severe combined immunodeficiency mouse models. Through systematic lipid-chain optimization, we identified 13i as a promising antiviral candidate with enhanced efficacy and favorable pharmaceutical properties.
More Related Videos
Related Concept Videos
Prodrugs
Prodrugs help overcome...
Subviral Agents
COP Coated Vesicles
Retroviruses
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents


